NIH Grant Success Rates Crater as Forward Funding Eats Into New Awards
March 24, 2026 · 2 min read
David Almeida
A national survey of nearly 1,000 NIH-funded researchers, published by STAT News on March 19, reveals the devastating scope of funding disruptions rippling through American biomedical science: more than 25 percent of respondents have laid off lab members, over 40 percent have canceled planned research, and two-thirds now advise students to pursue careers outside academia.
The Forward Funding Trap Squeezing New Awards
The crisis has a technical root with devastating consequences. In fiscal year 2024, only 5 to 15 percent of new NIH grants used forward funding — a practice of disbursing multiple years of grant money upfront in a single payment. By FY2025, that figure surged to roughly 40 percent, consuming future-year budgets and leaving less money for new awards.
The result: NIH awarded 5,564 fewer grants in FY2025 compared to FY2024 — an 8.6 percent drop. An estimated 970 additional new grants will vanish in FY2026 if the trend continues. At the National Cancer Institute, the payline collapsed from the ninth percentile to the fourth, meaning only the top 4 percent of proposals now receive funding. NCI awarded just 400 grants last year versus an anticipated 700.
Labs Closing and Careers Ending Across the Country
"This is like the Titanic hitting the iceberg," UCLA researcher Steve Shoptaw told STAT. "The ship is sinking."
The survey documented researchers closing labs entirely, one scientist cutting their salary by 95 percent to retain staff, and a diabetes clinical trial in Puerto Rico losing participants during funding gaps. Only 35 percent of researchers whose grants were cut or delayed have had funding fully restored. Among junior tenure-track faculty, 81 percent fear disruptions will cost them tenure.
Diversify Your Funding Sources Now
Congress set NIH's FY2026 budget at $47.2 billion — a nominal $216 million increase that amounts to a real cut after inflation. With 16 of 27 NIH institutes lacking appointed directors and paylines tightening across the board, researchers should begin diversifying into foundation funding, industry partnerships, and state research programs immediately. Grant discovery platforms like grantedai.com can surface alternative opportunities as federal competition reaches historic intensity.
In-depth analysis of NIH funding strategies and alternative funding sources is available on the Granted blog.